Date
2024-06-05Subject
150 Psychology 610 Medicine and health ParaphiliePädophilieAgonistRisikoRückfallReduktionGonadotropin-ReleasinghormonMetadata
Show full item record
Aufsatz
The impact of testosterone-lowering medication on recidivism in individuals convicted of sexual offenses
Abstract
Introduction: Treatment of individuals who have committed sexual offences with Testosterone-Lowering Medication (TLM) is a comparatively intrusive kind of intervention, which regularly takes place in coercive contexts. Thus, the question of efficacy, but also the question of who should be treated, when and for how long, are of great importance. Methods: Recidivism rates of TLM-treated high-risk individuals (þTLM; n¼54) were compared with high-risk individuals treated with psychotherapy only in the same forensic outpatient clinic (−TLM; n¼79). Results: Group differences suggested a higher initial risk ofþTLM (e.g. higher ris-assessment, previous convictions). Despite the increased risk, after an average time at risk of six years, þTLM recidivated significantly less often and significantly later than−TLM (27.8% vs. 51.9%). Such an effect was also found for violent (1.9% vs. 15.2%), but not for sexual (5.6% vs. 10.1%) and serious recidivism (5.6% vs. 10.1%), which could be explained partly by the small number of cases. In the course of treatment, TLM proved to be a significant variable for a positive process, whereas a high risk-assessment score indicated a rather negative course. In total, n¼19 individuals had stopped their TLM treatment, of these 31.6% recidivated. Conclusion: The results support the efficacy of TLM, particularly in the group of high-risk offenders.
Citation
In: Dialogues in Clinical Neuroscience Volume 26 / Issue 1 (2024-06-05) , S. 28 - 37 ; eissn:1958-5969Sponsorship
Gefördert durch den Publikationsfonds der Universität KasselCitation
@article{doi:10.17170/kobra-2024070810477,
author={Sauter, Julia and Lingenti, Laura M. and Rettenberger, Martin and Turner, Daniel and Briken, Peer and Voß, Tatjana},
title={The impact of testosterone-lowering medication on recidivism in individuals convicted of sexual offenses},
journal={Dialogues in Clinical Neuroscience},
year={2024}
}
0500 Oax 0501 Text $btxt$2rdacontent 0502 Computermedien $bc$2rdacarrier 1100 2024$n2024 1500 1/eng 2050 ##0##http://hdl.handle.net/123456789/15902 3000 Sauter, Julia 3010 Lingenti, Laura M. 3010 Rettenberger, Martin 3010 Turner, Daniel 3010 Briken, Peer 3010 Voß, Tatjana 4000 The impact of testosterone-lowering medication on recidivism in individuals convicted of sexual offenses / Sauter, Julia 4030 4060 Online-Ressource 4085 ##0##=u http://nbn-resolving.de/http://hdl.handle.net/123456789/15902=x R 4204 \$dAufsatz 4170 5550 {{Paraphilie}} 5550 {{Pädophilie}} 5550 {{Agonist}} 5550 {{Risiko}} 5550 {{Rückfall}} 5550 {{Reduktion}} 5550 {{Gonadotropin-Releasinghormon}} 7136 ##0##http://hdl.handle.net/123456789/15902
2024-07-09T10:18:49Z 2024-07-09T10:18:49Z 2024-06-05 doi:10.17170/kobra-2024070810477 http://hdl.handle.net/123456789/15902 Gefördert durch den Publikationsfonds der Universität Kassel eng Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Antiandrogens GnRHagonists recidivism risk paraphilic disorder paedophilic disorder 150 610 The impact of testosterone-lowering medication on recidivism in individuals convicted of sexual offenses Aufsatz Introduction: Treatment of individuals who have committed sexual offences with Testosterone-Lowering Medication (TLM) is a comparatively intrusive kind of intervention, which regularly takes place in coercive contexts. Thus, the question of efficacy, but also the question of who should be treated, when and for how long, are of great importance. Methods: Recidivism rates of TLM-treated high-risk individuals (þTLM; n¼54) were compared with high-risk individuals treated with psychotherapy only in the same forensic outpatient clinic (−TLM; n¼79). Results: Group differences suggested a higher initial risk ofþTLM (e.g. higher ris-assessment, previous convictions). Despite the increased risk, after an average time at risk of six years, þTLM recidivated significantly less often and significantly later than−TLM (27.8% vs. 51.9%). Such an effect was also found for violent (1.9% vs. 15.2%), but not for sexual (5.6% vs. 10.1%) and serious recidivism (5.6% vs. 10.1%), which could be explained partly by the small number of cases. In the course of treatment, TLM proved to be a significant variable for a positive process, whereas a high risk-assessment score indicated a rather negative course. In total, n¼19 individuals had stopped their TLM treatment, of these 31.6% recidivated. Conclusion: The results support the efficacy of TLM, particularly in the group of high-risk offenders. open access Sauter, Julia Lingenti, Laura M. Rettenberger, Martin Turner, Daniel Briken, Peer Voß, Tatjana doi:10.1080/19585969.2024.2359923 Paraphilie Pädophilie Agonist Risiko Rückfall Reduktion Gonadotropin-Releasinghormon publishedVersion eissn:1958-5969 Issue 1 Dialogues in Clinical Neuroscience 28 - 37 Volume 26 false
The following license files are associated with this item: